Okay, let's tackle this question about nocturnal enuresis. The question is asking which treatment has the lowest recurrence rate. First, I need to recall the core concept here. Nocturnal enuresis, or bedwetting, is common in children. The main treatments include behavioral interventions, alarm therapy, and medications like desmopressin. The key is to determine which of these has the lowest recurrence after treatment.

The core concept here is probably about the long-term effectiveness of different treatments. I remember that desmopressin works by reducing nighttime urine production, but once you stop it, the effect might not last. On the other hand, alarm therapy is supposed to train the bladder and possibly the child's response to the urge to urinate, leading to longer-lasting results.

So, the correct answer is likely the alarm therapy. Why? Because it's a behavioral intervention that teaches the body to respond to the urge, which should reduce recurrence even after stopping treatment. Desmopressin, while effective during use, doesn't address the underlying cause, so recurrence is higher once the medication is stopped.

Now, looking at the options, if the correct answer is C, for example, then the other options like desmopressin (maybe option B) would be incorrect because they have higher recurrence rates. Other options might include things like anticholinergics or other behavioral methods, but alarm therapy is the gold standard for long-term success.

Clinical pearls: The alarm therapy is associated with the lowest relapse rates. Students should remember that while medication provides quick results, behavioral therapies offer more sustained outcomes. Also, desmopressin's effect is temporary, so recurrence is higher.

**Core Concept**
Nocturnal enuresis management involves behavioral therapies and pharmacologic agents. Recurrence rates post-treatment depend on mechanisms addressing underlying pathophysiology, such as bladder control training versus temporary symptom suppression.

**Why the Correct Answer is Right**
Alarm therapy (e.g., enuresis alarms) trains the child to respond to the urge to void during sleep by interrupting the enuresis cycle. This method directly targets neurophysiological pathways responsible for bladder control, leading to **sustained remission** and **lowest recurrence rates** (70–80% success without relapse). It enhances nocturnal arousal and bladder capacity over time.

**Why Each Wrong Option is Incorrect**
**Option A:** Desmopressin reduces antidiuretic hormone deficiency but only suppresses urine production temporarily. Recurrence is high (50–70%) after discontinuation.
**Option B:** Anticholinergics (e.g., oxybutynin) improve bladder storage but do not address arousal mechanisms, leading to moderate recurrence rates (40–60%).
**Option D:** Combination therapy (desmopressin + alarms) increases short-term efficacy but lacks long-term data; recurrence rates are intermediate.

**Clinical Pearl / High-Yield Fact**
**Alarm therapy is the first-line treatment for primary monosymptomatic nocturnal enuresis** due to its durability. Avoid relying solely on desmopressin for long-term management—it is a "bridge" therapy, not a cure.

**Correct Answer: C. Alarm therapy**

✓ Correct Answer: A. Bed alarms